Figure 1.
(A, B) Schematic representation of the PTH1R and its biotechnological ligands (tethered or GFP conjugated) discussed or exploited in the present text. (C) Schematic representation of the BK B2R and its GFP-conjugated ligand based on maximakinin (MK).